Peptide News

A static news aggregator refreshed from FDA MedWatch, PubMed, and ClinicalTrials.gov so the site can surface real signal without inventing headlines.

Latest sync: Jul 13, 2026, 4:50 AM. This page favors official and public primary sources over generic news scraping.

Display order is chronological from newest to oldest; future-dated or recently indexed items are pushed to the end.

FDA safety feed
0

Status: live

PubMed research watch
12

Status: live

ClinicalTrials.gov updates
11

Status: live

Tracked topics
semaglutideglp-1obesitytirzepatideretatrutideweight losstesamorelinbpc-157

Newest peptide and GLP-1 updates

A rolling stream of the most recent official and public-source items in the tracker. Future-dated PubMed indexing artifacts stay at the bottom.

ClinicalTrials.gov Trials

Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity

Semaglutide • RECRUITING • Washington University School of Medicine

SemaglutideRECRUITINGINTERVENTIONAL
3 days ago Jul 10, 2026
ClinicalTrials.gov Trials

Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

Tirzepatide • RECRUITING • National and Kapodistrian University of Athens

TirzepatideRECRUITINGOBSERVATIONAL
3 days ago Jul 10, 2026
ClinicalTrials.gov Trials

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

Semaglutide • RECRUITING • National Institutes of Health Clinical Center (CC)

SemaglutideRECRUITINGINTERVENTIONAL
3 days ago Jul 10, 2026
PubMed Research

Retatrutide fact check: Has a man died after taking the unapproved weight loss jab?

BMJ • Retatrutide • Journal Article

RetatrutideJournal Article
4 days ago Jul 9, 2026
ClinicalTrials.gov Trials

Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.

Tirzepatide • COMPLETED • Brigham and Women's Hospital

TirzepatideCOMPLETEDOBSERVATIONAL
4 days ago Jul 9, 2026
ClinicalTrials.gov Trials

INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)

Tirzepatide • COMPLETED • Brigham and Women's Hospital

TirzepatideCOMPLETEDOBSERVATIONAL
4 days ago Jul 9, 2026
PubMed Research

Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.

BMJ • Retatrutide • Systematic Review

RetatrutideSystematic ReviewNetwork Meta-AnalysisJournal Article
5 days ago Jul 8, 2026
PubMed Research

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol.

BMJ Open • Tesamorelin • Journal Article

TesamorelinJournal ArticleClinical Trial Protocol
5 days ago Jul 8, 2026
ClinicalTrials.gov Trials

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Retatrutide • RECRUITING • Eli Lilly and Company

RetatrutideRECRUITINGINTERVENTIONAL
6 days ago Jul 7, 2026
PubMed Research

Effects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats.

Behav Brain Res • Retatrutide • Journal Article

RetatrutideJournal Article
12 days ago Jul 1, 2026
PubMed Research

Effect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid Levels: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

High Blood Press Cardiovasc Prev • Retatrutide • Journal Article

RetatrutideJournal ArticleReview
14 days ago Jun 29, 2026
PubMed Research

Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices.

Analyst • BPC-157 • Journal Article

BPC-157Journal Article
21 days ago Jun 22, 2026
ClinicalTrials.gov Trials

A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia

Retatrutide • COMPLETED • Eli Lilly and Company

RetatrutideCOMPLETEDINTERVENTIONAL
25 days ago Jun 18, 2026
ClinicalTrials.gov Trials

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Retatrutide • ACTIVE_NOT_RECRUITING • Eli Lilly and Company

RetatrutideACTIVE_NOT_RECRUITINGINTERVENTIONAL
26 days ago Jun 17, 2026
PubMed Research

Understanding reasons for initiation and experience with tirzepatide among individuals with obesity or overweight: Results from the PERCEPTIONS survey.

Obes Pillars • Tirzepatide • Journal Article

TirzepatideJournal Article
26 days ago Jun 17, 2026
PubMed Research

The effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment.

eNeurologicalSci • Tesamorelin • Journal Article

TesamorelinJournal Article
26 days ago Jun 17, 2026
PubMed Research

Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach.

Pharmaceuticals (Basel) • BPC-157 • Journal Article

BPC-157Journal Article
44 days ago May 30, 2026
PubMed Research

BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase.

Int J Mol Sci • BPC-157 • Journal Article

BPC-157Journal Article
44 days ago May 30, 2026
PubMed Research

Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury.

Sci Rep • BPC-157 • Journal Article

BPC-157Journal Article
46 days ago May 28, 2026
ClinicalTrials.gov Trials

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

Tesamorelin • RECRUITING • Massachusetts General Hospital

TesamorelinRECRUITINGINTERVENTIONAL
55 days ago May 19, 2026
ClinicalTrials.gov Trials

Body Composition and Adipose Tissue in HIV

Tesamorelin • TERMINATED • Columbia University

TesamorelinTERMINATEDINTERVENTIONAL
55 days ago May 19, 2026
PubMed Research

Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications.

JBJS Rev • Tesamorelin • Journal Article

TesamorelinJournal ArticleReview
73 days ago May 1, 2026
ClinicalTrials.gov Trials

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

Tesamorelin • RECRUITING • Hudson Biotech

TesamorelinRECRUITINGINTERVENTIONAL
116 days ago Mar 19, 2026

This page is built from a generated JSON snapshot refreshed by scheduled syncs, not from a live browser request. FDA items come from RSS feeds, PubMed items come from NCBI utilities, and study updates come from the ClinicalTrials.gov API. The page is date-ordered for readability, while the underlying generator still scores relevance for homepage surfacing and future editorial modules.